Literature DB >> 8750919

Interaction of class III antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.

H Uemura1, Y Hara, M Endou, K Mori, H Nakaya.   

Abstract

We have recently reported that class III antiarrhythmic drugs inhibit the muscarinic acetylcholine (ACh) receptor-operated K+ current (IK,ACh) in guinea-pig atrial cells by different molecular mechanisms. The data obtained from the patch-clamp study suggest that D,L-sotalol inhibits IK,ACh by blocking the muscarinic receptors, whereas MS-551 inhibits the K+ current by blocking the muscarinic receptors and depressing the function of the K+ channel itself and/or the guanine nucleotide-binding protein (G protein). This study was undertaken to determine whether the class III antiarrhythmic drugs D,L-sotalol and MS-551 interact with the muscarinic receptors of cardiac and peripheral tissues. Both drugs inhibited concentration dependently the specific [3H]N-methylscopolamine ([3H]-NMS) binding to membrane preparations obtained from guinea-pig atria and submandibular glands. The competition curves of these drugs for [3H]-NMS binding to glandular membranes were monophasic, suggesting competition with [3H]-NMS at a single site. Although the competition curve of D,L-sotalol for [3H]-NMS binding to atrial membranes was monophasic, that of MS-551 was biphasic and showed high- and low-affinity states of binding. D,L-Sotalol showed slightly, but significantly, higher affinity for cardiac-type muscarinic receptors (M2) than for glandular-type muscarinic receptors (M3). The inhibition constant (Ki) for MS-551 in glandular membranes was also slightly greater than the high-affinity Ki value for the drug in atrial membranes. In guinea-pig left atria and ilea, D,L-sotalol shifted the concentration-response curves for the negative inotropic effect and the contracting effect of carbachol in a parallel manner. The slopes of Schild plot were not significantly different from unity, suggesting competitive antagonism, and the pA2 for D,L-sotalol in left atria was slightly greater than that in ilea. MS-551 also shifted the concentration response curve for the negative inotropic effect of carbachol in atrial preparations to a greater extent than that for the contracting effect in ileal preparations, although MS-551 failed to show a pure competitive antagonism. These results suggest that both D,L-sotalol and MS-551 interact with cardiac M2 and peripheral M3 receptors, and that at high concentrations they exert anticholinergic activity in cardiac and peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750919     DOI: 10.1007/bf00168918

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.

Authors:  M Endou; Y Hattori; S Gando; M Kanno
Journal:  J Cardiovasc Pharmacol       Date:  1992-05       Impact factor: 3.105

2.  Prediction of sotalol-induced maximum steady-state QTc prolongation from single-dose administration in healthy volunteers.

Authors:  F Le Coz; C Funck-Brentano; J M Poirier; Y Kibleur; F X Mazoit; P Jaillon
Journal:  Clin Pharmacol Ther       Date:  1992-10       Impact factor: 6.875

Review 3.  The molecular basis of muscarinic receptor diversity.

Authors:  T I Bonner
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

4.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

5.  Anti-cholinergic effects of quinidine, disopyramide, and procainamide in isolated atrial myocytes: mediation by different molecular mechanisms.

Authors:  T Nakajima; Y Kurachi; H Ito; R Takikawa; T Sugimoto
Journal:  Circ Res       Date:  1989-02       Impact factor: 17.367

6.  Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

Authors:  S Juul-Möller; N Edvardsson; N Rehnqvist-Ahlberg
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

7.  Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.

Authors:  K Mori; Y Hara; T Saito; Y Masuda; H Nakaya
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Inhibitory effects of quinidine on rat heart muscarinic receptors.

Authors:  M Waelbroeck; P De Neef; P Robberecht; J Christophe
Journal:  Life Sci       Date:  1984-09-03       Impact factor: 5.037

10.  Molecular mechanism of cibenzoline-induced anticholinergic action in single atrial myocytes: comparison with effect of disopyramide.

Authors:  S N Wu; T Nakajima; T Yamashita; E Hamada; H Hazama; K Iwasawa; M Omata; Y Kurachi
Journal:  J Cardiovasc Pharmacol       Date:  1994-04       Impact factor: 3.105

View more
  1 in total

1.  Inhibitory effects of JTV-519, a novel cardioprotective drug, on potassium currents and experimental atrial fibrillation in guinea-pig hearts.

Authors:  H Nakaya; Y Furusawa; T Ogura; M Tamagawa; H Uemura
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.